Linear and Circular Long Non-Coding RNAs in Acute Lymphoblastic Leukemia: From Pathogenesis to Classification and Treatment.
Linear and Circular Long Non-Coding RNAs in Acute Lymphoblastic Leukemia: From Pathogenesis to Classification and Treatment.
复制标题
急性淋巴细胞白血病中的线性和环状长非编码 RNA:从发病机制到分类和治疗
DOI:
10.3390/ijms23084442
复制
发表时间:
2022-04-18
影响因子:
5.6
通讯作者:
中科院分区:
文献类型:
--
作者:
The coding regions account for only a small part of the human genome, and the remaining vast majority of the regions generate large amounts of non-coding RNAs. Although non-coding RNAs do not code for any protein, they are suggested to work as either tumor suppressers or oncogenes through modulating the expression of genes and functions of proteins at transcriptional, posttranscriptional and post-translational levels. Acute Lymphoblastic Leukemia (ALL) originates from malignant transformed B/T-precursor-stage lymphoid progenitors in the bone marrow (BM). The pathogenesis of ALL is closely associated with aberrant genetic alterations that block lymphoid differentiation and drive abnormal cell proliferation as well as survival. While treatment of pediatric ALL represents a major success story in chemotherapy-based elimination of a malignancy, adult ALL remains a devastating disease with relatively poor prognosis. Thus, novel aspects in the pathogenesis and progression of ALL, especially in the adult population, need to be further explored. Accumulating evidence indicated that genetic changes alone are rarely sufficient for development of ALL. Recent advances in cytogenic and sequencing technologies revealed epigenetic alterations including that of non-coding RNAs as cooperating events in ALL etiology and progression. While the role of micro RNAs in ALL has been extensively reviewed, less attention, relatively, has been paid to other non-coding RNAs. Herein, we review the involvement of linear and circular long non-coding RNAs in the etiology, maintenance, and progression of ALL, highlighting the contribution of these non-coding RNAs in ALL classification and diagnosis, risk stratification as well as treatment.
登录
查看更多内容
影响因子:
5.7
作者:
通讯作者:
--
影响因子:
2.3
作者:
Bahari, Gholamreza;Hashemi, Mohammad;Taheri, Mohsen
通讯作者:
Taheri, Mohsen
影响因子:
--
作者:
Andreasson, P;Schwaller, J;Gilliland, DG
通讯作者:
Gilliland, DG
影响因子:
3.5
作者:
Alberto Barcenas-Lopez, Diego;Carlos Nunez-Enriquez, Juan;Jimenez-Morales, Silvia
通讯作者:
Jimenez-Morales, Silvia
影响因子:
2.6
作者:
Abuduer, Muhebaier;Gu, A. Er Zi
通讯作者:
Gu, A. Er Zi